A Fibrosis Score estimates how much scarring (fibrosis) is present in your liver without a biopsy. It combines routine blood tests (and sometimes age/height/weight) in a validated formula to classify your risk of advanced fibrosis (significant scarring that can progress to cirrhosis). Clinicians use it to rule out low risk, flag high risk, and decide who needs imaging (e.g., transient elastography/FibroScan®), specialist referral, or closer follow-up.
When it’s ordered
-
Suspected or known fatty liver disease (NAFLD/MASLD or NASH)
-
Chronic hepatitis B or C
-
Alcohol-related liver disease
-
Metabolic risk (obesity, type 2 diabetes, dyslipidemia)
-
Persistently abnormal ALT/AST
-
To monitor change in fibrosis risk over time
How it’s calculated (the common scores)
Different “fibrosis scores” exist. Your report may name one specifically, or simply list “Fibrosis Score.” The most common are:
1) FIB-4 Index
Inputs: Age, AST, ALT, Platelets
Typical cutoffs (age <65):
-
< 1.3 → Low risk of advanced fibrosis
-
1.3–2.67 → Indeterminate
-
> 2.67 → High risk of advanced fibrosis
Note: In adults ≥65, the low-risk threshold is often raised to < 2.0 to reduce false positives.
2) NAFLD Fibrosis Score (NFS)
Inputs: Age, BMI, Diabetes/Impaired fasting glucose, AST, ALT, Platelets, Albumin
Cutoffs:
-
< −1.455 → Low risk
-
−1.455 to 0.676 → Indeterminate
-
> 0.676 → High risk
3) APRI (AST-to-Platelet Ratio Index)
Inputs: AST, AST upper limit of normal (ULN), Platelets
Common interpretive anchors:
-
Around 0.5 → low probability of significant fibrosis
-
Around 1.5 → higher probability of significant fibrosis
(Programs may use slightly different cutoffs for “significant” vs “advanced” fibrosis.)
4) ELF® (Enhanced Liver Fibrosis) Score
Inputs: Hyaluronic acid, P3NP, TIMP-1 (specialized markers)
Risk tiers (lab-specific): values typically ~9.8–10.5 indicate increasing fibrosis risk; higher numbers suggest higher probability of advanced fibrosis. Exact thresholds vary by lab and clinical setting.
Always interpret your number using the reference ranges printed on your report, because cutoffs and units can differ by laboratory and clinical guideline.
Understanding your result
Low-risk range
-
Suggests little to no advanced fibrosis right now.
-
Usual plan: reinforce liver-healthy habits and periodic re-check (e.g., every 1–3 years, sooner if risk changes).
Indeterminate range
-
Means uncertain: cannot confidently exclude or confirm advanced fibrosis.
-
Usual plan: second-line testing, often a FibroScan® (liver stiffness) or another fibrosis score, review medications, and repeat labs after addressing reversible factors.
High-risk range
-
Indicates a higher probability of advanced fibrosis (possible stage F3–F4).
-
Usual plan: hepatology referral, liver stiffness measurement, imaging, evaluation for complications, and a treatment plan specific to the cause (metabolic, viral, alcohol-related, etc.).
What can skew the score?
-
Acute illness or flares (AST/ALT temporarily high)
-
Recent strenuous exercise (can raise AST)
-
Alcohol use in the last days/weeks
-
Medications or supplements affecting liver enzymes or platelets
-
Thrombocytopenia from non-liver causes
-
Age ≥65 (raises FIB-4 even with modest enzyme changes)
-
Pregnancy, hemolysis, or lab variability
If any of these apply, your clinician may repeat testing after stabilization.
What to do next
If Low Risk
-
Maintain or adopt liver-healthy habits:
-
Weight management; aim for 7–10% weight loss if overweight
-
Mediterranean-style eating pattern; limit fructose-sweetened drinks and ultra-processed foods
-
Alcohol: avoid or minimize
-
Regular physical activity (aerobic + resistance)
-
-
Reassess the score and liver enzymes periodically.
If Indeterminate
-
Ask about FibroScan®, repeat labs in 3–6 months after lifestyle optimization, and evaluation for other causes (viral hepatitis, medications, autoimmune hepatitis, hemochromatosis, Wilson disease if indicated).
-
Consider a second score (e.g., FIB-4 + NFS) to improve confidence.
If High Risk
-
Specialist referral and confirmatory liver stiffness assessment.
-
Cause-specific therapy:
-
Metabolic dysfunction (MASLD/NASH): structured weight loss, diabetes control (consider GLP-1 RA/SGLT2i where appropriate), lipid management.
-
Viral hepatitis: antiviral evaluation/treatment.
-
Alcohol-related: cessation support programs and nutritional care.
-
-
Vaccinate against HAV/HBV if non-immune; manage cardiovascular and renal risks.
FAQs
Does a low score mean my liver is normal?
It means advanced scarring is unlikely right now. You can still have fat accumulation or inflammation; keep working on liver-healthy habits and follow up as advised.
Can fibrosis scores replace liver biopsy?
They are excellent triage tools. In unclear or high-risk cases, clinicians may still use elastography or occasionally biopsy to confirm stage and guide treatment.
How fast can scores change?
With meaningful lifestyle or disease-specific treatment, scores can improve over months. Re-testing intervals depend on your risk and care plan.
Key takeaways
-
“Fibrosis Score” is a non-invasive estimate of liver scarring using routine blood tests.
-
Results are grouped into low, indeterminate, or high risk for advanced fibrosis.
-
Use your lab’s exact cutoffs and confirm indeterminate/high results with liver stiffness testing.
-
Address the root cause (metabolic, viral, alcohol-related) to slow, stop, or even reverse early disease.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.